C07D231/46 - CPC Classification Index

ClassID:

94381 ⎘

C07D231/46 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Oxygen and nitrogen or sulfur and nitrogen atoms Oxygen atom in position 3 or 5 and nitrogen atom in position 4

Sub-classes:

C07D231/48 » with hydrocarbon radicals attached to said nitrogen atom 19
C07D231/50 » Acylated on said nitrogen atom 15

Recent Application in this class:

20240043389

2024-02-08

COMPOUNDS AND METHODS FOR INHIBITION OF BAX-MEDIATED CELL DEATH

20220298116

2022-09-22

PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF ELTROMBOPAG OR SALT THEREOF

20210284611

2021-09-16

Highly stable crystalline Eltrombopag monoethanolamine salt form D1

20210198211

2021-07-01

Crystalline Eltrombopag monoethanolamine salt form D

20210046045

2021-02-18

Methods and compositions associated with the granulocyte colony-stimulating factor receptor

20200331862

2020-10-22

Solid state forms of eltrombopag choline

20190316174

2019-10-17

Reaction accelerating agent

20190209479

2019-07-11

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)

20190022066

2019-01-24

Pyrazole derivatives and their uses thereof

#10

20180369197

2018-12-27

Methods and compositions associated with the granulocyte colony-stimulating factor receptor

#11

20180338926

2018-11-29

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)

#12

20180318308

2018-11-08

Pyrazolone derivatives as nitroxyl donors

#13

20180273490

2018-09-27

Process for the Preparation of Eltrombopag Olamine

#14

20170275255

2017-09-28

Crystalline form of Eltrombopag free acid

#15

20170050947

2017-02-23

Meldrum's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as HNO donors

#16

20160374989

2016-12-29

Methods and compositions associated with the granulocyte colony-stimulating factor receptor

#17

20160305969

2016-10-20

Mass spectrometric identification and/or quantitation of catecholamines using aminopyrazoles

#18

20160115148

2016-04-28

N-substituted hydroxylamine derivatives with carbon-based leaving groups

#19

20160031822

2016-02-04

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)

#20

20160022640

2016-01-28

Pyrazole derivatives and their uses thereof

#21

20150344437

2015-12-03

Pyrazolone derivatives as nitroxyl donors

#22

20150291534

2015-10-15

Compounds for treating HIV and methods for using the compounds

#23

20150093356

2015-04-02

THROMBOPOIETIN MIMETICS

#24

20150087845

2015-03-26

Process for preparation of substituted 3'-hydroazino-diphenyl-3-carboxylic acid compounds

#25

20150079030

2015-03-19

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)

#26

20140296292

2014-10-02

Methods and compositions associated with the granulocyte colony-stimulating factor receptor

#27

20140275134

2014-09-18

Meldrum's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as HNO donors

#28

20140140953

2014-05-22

Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof

#29

20140078577

2014-03-20

AZO compound and ink containing the compound

#30

20140037580

2014-02-06

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#31

20130116203

2013-05-09

ISOTHIOCYNATES AND GLUCOSINOLATE COMPOUNDS AND ANTI-TUMOR COMPOSITIONS CONTAINING SAME

#32

20130078213

2013-03-28

THROMBOPOIETIN MIMETICS

#33

20120323017

2012-12-20

Dinitropyrazole derivatives, their preparation, and energetic compositions comprising them

#34

20120238612

2012-09-20

Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof

#35

20120189576

2012-07-26

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)

#36

20120164102

2012-06-28

Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof

#37

20120093927

2012-04-19

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#38

20120022124

2012-01-26

Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof

#39

20110212054

2011-09-01

THROMBOPOIETIN MIMETICS

#40

20110196008

2011-08-11

Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof

#41

20110081312

2011-04-07

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#42

20110003851

2011-01-06

Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors

#43

20100323965

2010-12-23

Thrombopoietin mimetics

#44

20100256212

2010-10-07

Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof

#45

20100129352

2010-05-27

NOVEL PHARMACEUTICAL COMPOSITION

#46

20100062464

2010-03-11

Oxidative chromogenic compound or salt thereof and production method thereof, and reagent composition and test instrument using the same

#47

20100047348

2010-02-25

3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#48

20100047347

2010-02-25

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1 ,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#49

20100047346

2010-02-25

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#50

20100040684

2010-02-18

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#51

20100040683

2010-02-18

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#52

20090291995

2009-11-26

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#53